Intelligence / Healthtech / Health Funding Register / Monocacy Therapeutics Inc.
Fundingraised $4921 Sept 2026
Monocacy Therapeutics Inc.
21 Sept 2026: Raised $49 · Monrovia, MD. Recorded in the SEC Form D data sets.
- Filed
- 21 Sept 2026
- Location
- Monrovia, MD
- State
- Maryland
- Industry
- Biotechnology
- Amount raised
- $49
- Offering size
- $49
- Revenue range
- Decline to Disclose
- Year of incorporation
- 2025
- Entity type
- Corporation
- Jurisdiction
- Delaware
- First sale
- 2026-09-03
- Securities
- Equity
- Investors so far
- 1
- SEC CIK
- 0002137361
What this signal means
Companies buy in the months after they raise: new hires, new vendors, new markets.
- 137 added in the 30 days to 30 Sept 2026.
- 114 of them (29%) raised $5M or more.
Reach them with AOS
Find the decision makers at Monocacy Therapeutics Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this funding signal, for your approval.
More from Maryland
Health Funding Register
24 SeptAromha, Inc.raised $75K · Potomac, MDFunding24 SeptSeraxis Holdings, Inc.raised $10.0M · Germantown, MDFunding23 SeptUvantis Therapeutics, Inc.raised $100K · Columbia, MDFunding21 SeptFunctional Longevity Labs, Inc.raised $25K · Easton, MDFunding16 SeptTerrace Systems, Inc.raised $250K · Silver Spring, MDFunding11 SeptSavannah Therapeutics, Incraised $3.9M · Riverdale, MDFunding
Source: SEC Form D data sets, data to 30 Sept 2026. New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC. AOS shows what the public record says; it does not verify or endorse the company.